Profile picture

Professor Alberico Catapano

IRCCS - MultiMedica, Milan (Italy)
Follow
Biography
Alberico Catapano is Full Professor of Pharmacology and Director of the Center of Epidemiology and Preventive Pharmacology at the University of Milan, as well as Director of the Laboratory of Lipoproteins, Immunity and Atherosclerosis and the Center for the Study of Atherosclerosis at Bassini Hospital, and at Multimedica IRCCS Milan, Italy. His main research interests include the study of atherosclerosis, lipids, lipoproteins and genetic dyslipidaemias, and he has made landmark observations regarding heat shock proteins and pentraxins in atherogenesis, on high-density lipoproteins in the modulation of the immune response, and on the identification of possible therapeutic targets by exploiting genetic information. A past President of the European Atherosclerosis Society (EAS), Professor Catapano is currently Co-Chairman of the EAS/European Society of Cardiology (ESC) guidelines for dyslipoproteinaemias, President of the Italian Society of Clinical and Experimental Therapeutics
Logo ESC

Contributor content

Risk factors (2)
Session
Risk factors (2)
30 August 2025
Diabetes, obesity, and the heart
Session
Diabetes, obesity, and the heart
1 September 2024
Great Debate: should we still target triglycerides to decrease cardiovascular risk?
Session
Great Debate: should we still target triglycerides to decrease cardiovascular risk?
28 August 2023
Are we achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals in real life?
Session
Are we achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals in real life?
27 August 2023
Combination therapy at the heart of lipid lowering management
Session
Combination therapy at the heart of lipid lowering management
14 April 2023
EAS Consensus on Lp(a) 2022 - what to measure, in whom to measure, how to interpret and what to do
Session
EAS Consensus on Lp(a) 2022 - what to measure, in whom to measure, how to interpret and what to do
29 August 2022
Dyslipidemia Challenge - Closing the Gap Between Guidelines and Clinical Practice
Session
Dyslipidemia Challenge - Closing the Gap Between Guidelines and Clinical Practice
30 August 2021
Lipid lowering beyond LDL-cholesterol and statins
Session
Lipid lowering beyond LDL-cholesterol and statins
28 August 2021
Managing patients with dyslipidaemia: how to tackle clinical inertia
Session
Managing patients with dyslipidaemia: how to tackle clinical inertia
30 August 2020
Lipid Treatment in very high risk ASCVD patient
Session
Lipid Treatment in very high risk ASCVD patient
3 September 2019

ESC 365 is supported by